SOUTHLAKE, Texas-Thursday, January 4th 2018 [ AETOS Wire ]

(BUSINESS WIRE) -- HeartSciences, a medical device company recently selected as a finalist for the Fierce Innovation Awards in the Digital Health Solution category, will be presenting in San Francisco at the BioTech Showcase. HeartSciences has two scheduled presentations: (1) Tuesday, January 9 at the BioTech Showcase at 2:45pm at the Hilton Hotel, Union Square and (2) Wednesday, January 10 at the Digital Medicine and Technology Showcase at 10:00am, at the Parc 55 Hotel.

HeartSciences is advancing the field of electrocardiology in combining the latest research and understanding of heart disease with the patented use of wavelet mathematics and artificial intelligence to develop medical devices for the early detection of heart disease. Its MyoVista hsECG (high sensitivity ECG), is designed to significantly improve the sensitivity of a diagnostic electrocardiology device in detecting ischemic and structural hear ... Read more »

 Entrust Datacard partners with Identity Management Systems (a subsidiary of Margins Group) to deliver first nationwide instant issuance in West Africa

MINNEAPOLIS-Thursday, January 4th 2018 [ AETOS Wire ]

(BUSINESS WIRE) -- Entrust Datacard, a leading provider of trusted identity and secure transaction technology solutions, today announced its technology will be used by the government of Ghana — through a partnership with Identity Management Systems (IMS), a subsidiary of Margins Group — to instantly issue national identity cards to Ghanaian citizens.

In line with the directive from the Government of Ghana to roll out the National Identification System (NIS), the National Identification Authority (NIA) will be responsible for ID card registration and instant issuance across Ghana. The new “GhanaCard” meets all international requirements for identity documents, such as chip-embedded technology and biometric capabilities. This is t ... Read more »

LAUSANNE, Switzerland-Thursday, January 4th 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- WayRay, a Swiss developer of holographic AR navigation systems for cars, is coming to CES 2018 to demonstrate cutting-edge technologies:

-NAVION, the world’s first ever holographic AR navigator

-An advanced version of the embedded Holographic AR Display

-True AR SDK for Holographic AR Displays

-Element, a gamified car tracker for smarter driving

NAVION gets its first ever public showcase after 4 years of R&D. For OEMs, WayRay will demonstrate the new multicolored version of the world’s first holographic AR Infotainment System for cars. Following the first successful demo in the Rinspeed Oasis Car at CES 2017, this year we are proud to show off its newest version. It has an extremely wide field of view and even smaller projector's volume. For developers, WayRay will demo our True AR SDK and announce the AR Developers Contest & Hacka ... Read more »

NEUCHATEL, Switzerland-Tuesday, January 2nd 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today the CE marking and release of RD rainbow Lite SET™ sensors, which enable the monitoring of Masimo Oxygen Reserve Index™ (ORi™) and RPVi™, an improved PVi® that allows clinicians to assess fluid responsiveness noninvasively and continuously1 at a fraction of the cost of invasive methods, and at a fraction of the cost of rainbow® sensors. rainbow Lite sensors utilize twice as many wavelengths of light as SET® sensors, allowing rainbow Lite sensors to provide ORi and RPVi along with Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry.

ORi is the first noninvasive and continuous parameter to provide insight into a patient’s oxygen reserve in the moderate hyperoxic range. In conjunction with SET® pulse oximetry, ORi may provide advanced warning of impending desaturation, which may a ... Read more »

 • The Boehringer Ingelheim Venture Fund (BIVF) extends its investment focus to include regenerative medicine, infectious diseases and digital health

• BIVF increases its presence in the United States and adds new staff members

• Through its successful investments in immune-oncology, the BIVF has helped the company elevate its presence across the global healthcare ecosystem and establish a new focus area

INGELHEIM, Germany & BOSTON-Wednesday, January 3rd 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Boehringer Ingelheim today announced an increase in funding for its corporate venture fund, known as the Boehringer Ingelheim Venture Fund (BIVF), from EUR 100 to 250 million. The additional funds will be used to invest in promising early stage start-up companies, focusing on regenerative medicine, infectious diseases and immune oncology among others, as well as growing the portfolio in the U.S. and opening doors for the BIVF in digital hea ... Read more »